Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:APTNASDAQ:BTCYNASDAQ:CTCXNASDAQ:MODD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPTAlpha Pro Tech$5.07+7.3%$4.50$4.06▼$6.44$55.08M0.331,362 shs129,034 shsBTCYBiotricity$0.56+1.8%$0.45$0.19▼$1.21$13.95M1.2235,321 shs26,178 shsCTCXCarmell$3.30-11.8%$0.83$0.17▼$2.65$68.99M0.513.80 million shs269,807 shsMODDModular Medical$0.78-9.1%$0.95$0.68▼$2.65$42.86M0.33208,222 shs126,652 shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPTAlpha Pro Tech0.00%+4.19%+6.79%-9.75%-5.60%BTCYBiotricity0.00%+7.84%+10.00%0.00%-48.60%CTCXCarmell0.00%+38.66%+1,780.34%+1,362.77%+32.53%MODDModular Medical0.00%-0.33%-18.27%+10.68%-47.85%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAPTAlpha Pro TechN/AN/AN/AN/AN/AN/AN/AN/ABTCYBiotricityN/AN/AN/AN/AN/AN/AN/AN/ACTCXCarmellN/AN/AN/AN/AN/AN/AN/AN/AMODDModular Medical1.5918 of 5 stars0.05.00.00.02.53.30.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPTAlpha Pro Tech 0.00N/AN/AN/ABTCYBiotricity 2.00HoldN/AN/ACTCXCarmell 0.00N/AN/AN/AMODDModular Medical 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPTAlpha Pro Tech$58.18M0.95$0.40 per share12.80$5.29 per share0.96BTCYBiotricity$12.06M1.16N/AN/A($1.30) per share-0.43CTCXCarmell$32.84K2,100.75N/AN/A$1.07 per share3.08MODDModular MedicalN/AN/AN/AN/A$0.25 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPTAlpha Pro Tech$4.19M$0.3713.70∞N/A6.99%6.70%5.76%N/ABTCYBiotricity-$14.09M-$1.08N/A∞N/A-80.42%N/A-188.47%6/25/2025 (Estimated)CTCXCarmell-$15.44MN/A0.00∞N/AN/A-217.50%-50.22%N/AMODDModular Medical-$17.47M-$0.53N/A∞N/AN/A-197.97%-162.31%6/20/2025 (Estimated)Latest BTCY, APT, CTCX, and MODD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/25/2025N/ABTCYBiotricity-$0.10N/AN/AN/A$3.60 millionN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAPTAlpha Pro TechN/AN/AN/AN/AN/ABTCYBiotricityN/AN/AN/AN/AN/ACTCXCarmellN/AN/AN/AN/AN/AMODDModular MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPTAlpha Pro TechN/A19.0011.21BTCYBiotricityN/A0.230.10CTCXCarmellN/A0.310.29MODDModular MedicalN/A5.305.30Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPTAlpha Pro Tech22.69%BTCYBiotricity3.89%CTCXCarmell24.22%MODDModular Medical27.47%Insider OwnershipCompanyInsider OwnershipAPTAlpha Pro Tech15.00%BTCYBiotricity10.10%CTCXCarmell29.00%MODDModular Medical20.46%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPTAlpha Pro Tech12010.86 million9.46 millionOptionableBTCYBiotricity4024.91 million22.08 millionOptionableCTCXCarmell1420.91 million14.84 millionNot OptionableMODDModular Medical2054.25 million32.35 millionNot OptionableBTCY, APT, CTCX, and MODD HeadlinesRecent News About These CompaniesModular Medical adds insulin delivery tech veteran to boardMay 29, 2025 | drugdeliverybusiness.comModular Medical, Inc.: Modular Medical Appoints Industry Veteran Jeff Goldberg to Board of DirectorsMay 29, 2025 | finanznachrichten.deModular Medical Appoints Industry Veteran Jeff Goldberg to Board of DirectorsMay 28, 2025 | accessnewswire.comRegistration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "Making Diabetes Management Simpler: The New Era of Insulin Therapy" Featuring Modular Medical CEO - Wednesday, May 28, 2025May 27, 2025 | accessnewswire.comModular Medical to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025May 22, 2025 | accessnewswire.comModular Medical files to sell 20.4M shares of common stock for holdersApril 26, 2025 | markets.businessinsider.comManchester Management Co Llc Acquires 156,250 Shares of Modular Medical, Inc. (NASDAQ:MODD) StockMarch 25, 2025 | insidertrades.comModular Medical announces $12M private placementMarch 21, 2025 | drugdeliverybusiness.comModular Medical, Inc.: Modular Medical Announces $12 Million Private PlacementMarch 20, 2025 | finanznachrichten.deModular Medical Announces $12 Million Private PlacementMarch 20, 2025 | accessnewswire.comModular Medical takes step forward in CE mark process for insulin pump techFebruary 3, 2025 | drugdeliverybusiness.comModular Medical Announces BSI Group as Trusted Body for CE Mark ClearanceJanuary 30, 2025 | accessnewswire.comModular Medical, Inc.: Modular Medical Announces Licensing and Partnership Agreement With Nudge BGDecember 19, 2024 | finanznachrichten.deModular Medical Announces Licensing and Partnership Agreement With Nudge BGDecember 19, 2024 | accesswire.comManchester Management Co Llc Buys 21,000 Shares of Modular Medical, Inc. (NASDAQ:MODD) StockDecember 5, 2024 | insidertrades.comModular Medical brings in $8.2MDecember 3, 2024 | drugdeliverybusiness.comModular Medical Announces Conference Call to Provide Business UpdateDecember 3, 2024 | finance.yahoo.comFavourable Signals For Modular Medical: Numerous Insiders Acquired StockDecember 2, 2024 | uk.finance.yahoo.comInsider Buying: Modular Medical, Inc. (NASDAQ:MODD) Director Buys 100,000 Shares of StockNovember 30, 2024 | insidertrades.comManchester Management Co Llc Purchases 166,666 Shares of Modular Medical, Inc. (NASDAQ:MODD) StockNovember 26, 2024 | insidertrades.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeBullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsBy Thomas Hughes | May 27, 2025View Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsIntel’s Turnaround May Be the Best Bet No One’s WatchingBy Jeffrey Neal Johnson | May 30, 2025View Intel’s Turnaround May Be the Best Bet No One’s Watching3 Different Ways to Add Gold to Your PortfolioBy Chris Markoch | May 29, 2025View 3 Different Ways to Add Gold to Your PortfolioMicrosoft and OpenAI Just Hit Reset—Here’s Why MSFT Stock WinsBy Chris Markoch | May 15, 2025View Microsoft and OpenAI Just Hit Reset—Here’s Why MSFT Stock WinsBTCY, APT, CTCX, and MODD Company DescriptionsAlpha Pro Tech NYSE:APT$5.07 +0.35 (+7.31%) As of 03:52 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Alpha Pro Tech, Ltd., together with its subsidiaries, develops, manufactures, and markets a range of disposable protective apparel, infection control, and building supply products in the United States and internationally. The company operates through Disposable Protective Apparel and Building Supply segments. The Disposable Protective Apparel segment provides shoe covers, bouffant caps, coveralls, frocks, lab coats, and gowns, hoods, as well as face masks and shields. The Building Supply segment offers construction weatherization products, such as housewrap and housewrap accessories, including window and door flashing, and seam tape, synthetic roof underlayment, and self-adhered roof underlayment, as well as other woven material. The company markets its products under the Alpha Pro Tech brand name, as well as under private labels. Its products are used primarily in cleanrooms; industrial safety manufacturing environments; health care facilities, such as hospitals, laboratories, and dental offices; building and re-roofing sites. The company distributes its products through a network of purchasing groups, distributors, and independent sales representatives, as well as through its sales and marketing force. Alpha Pro Tech, Ltd. was founded in 1983 and is headquartered in Markham, Canada.Biotricity NASDAQ:BTCY$0.56 +0.01 (+1.80%) As of 02:17 PM EasternBiotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.Carmell NASDAQ:CTCX$3.30 -0.44 (-11.76%) As of 05/30/2025Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. In addition, the company is also developing a line of men's products and a line of topical haircare products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Therapeutics Corporation and changed its name to Carmell Corporation in November 2023. Carmell Therapeutics Corporation was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.Modular Medical NASDAQ:MODD$0.78 -0.08 (-9.07%) As of 03:53 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Modular Medical, Inc. operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Buy The Dip in Okta, There’s Nothing Wrong With the Outlook Why SoundHound Could Be a Short Squeeze in the Making Why Schwab US Dividend Equity ETF Could Lead the Rotation Analysts Are Bullish on Marvell Stock Despite Amazon Deal Concern MarketBeat Week in Review – 05/26 - 05/30 Super Micro Computer Stock Finding Upside With NVIDIA's Blackwell 5 Reasons Costco Stock Will Hit New Highs This Year Ackman Takes a Swing at Amazon — Should You? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
